Journal of Clinical Pharmacy and Therapeutics · 2007 · 30 citations · 10 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyPharmacogeneticsPharmacogenomicsAntifungal AgentsAntifungal PharmacologyAntifungal PharmacotherapyAntifungal TherapyFungal InfectionsFungal PathogenesisAntifungal PharmacogenomicsAntifungal TreatmentsAntifungal-chemotherapy InteractionsArrhythmogenic MechanismsDrug-drug Interactions With AntifungalsMucormycosis PharmacotherapyMucormycosis TreatmentQt Interval Assessment
A 14-year-old Tahitian girl with acute myeloid leukaemia and a suspected mucormucosis infection was treated with intravenous voriconazole and caspofungin. Because of worsening of fungal infection, voriconazole was switched to posaconazole. During the switch, the patient presented with QT interval prolongation with 'torsades de pointes' and reversible cardiac arrest. Voriconazole plasma level measured 15 h after the last administration was 7 mg/L. Genotyping suggested that the patient was an extensive metabolizer with respect to CYP2C9 and CYP2C19. The association of antifungal agents with pro-arrhythmogenic drugs and other risk factors led to torsades de pointes and the revealing of inherited QT syndrome.
10
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Keith Tan, Nigel Brayshaw, Konrad E. Tomaszewski et al. · The Journal of Clinical Pharmacology · 2006 · 255 citations
Invasive Fungal Infections in Pediatric Oncology Patients
Galit Rosen, Karin Nielsen, Sungching Glenn et al. · Journal of Pediatric Hematology/Oncology · 2005 · 157 citations
Medicine, Oncology, Pediatrics +11